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Infectious cercariae of Schistosoma mansoni gain entry to the mammalian host through the skin where they induce a transient inﬂam-
matory inﬂux of mononuclear cells. Some of these cells have antigen-presenting cell function (MHCII+) and have been reported to
migrate to the skin-draining lymph nodes (sdLN) where they have the potential to prime CD4+ cells of the acquired immune response.
Here, in mice exposed to vaccinating radiation-attenuated schistosome larvae, which induce high levels of protective immunity to chal-
lenge infection, we describe the parasite-induced migration of Langerhans cells (LCs) from the epidermal site of immunisation to the
sdLN using a speciﬁc monoclonal antibody that recognises langerin (CD207). CD207+ cells with dendritic morphology were abundant
in the epidermis at all times and their migration into the dermis was detected soon after vaccination. All CD207+ LCs were MHCII+ but
not all MHCII+ cells in the skin were CD207+. LCs migrated from the dermis in enhanced numbers after vaccination, as detected in
dermal exudate populations recovered after in vitro culture of skin biopsies. Elevated numbers of CD207+ LCs were also detected in
the sdLN from 24 h to 4 days after vaccination. However, compared with other dermal-derived antigen-presenting cells that were
CD207MHCII+ or CD207CD11c+, the relative numbers of CD207+ cells in the dermal exudate population and in the sdLN were
very small. Furthermore, the migration of CD207+ cells after exposure to ‘protective’ radiation-attenuated, compared with ‘non-protec-
tive’ normal cercariae, was similar in terms of numbers and kinetics. Together, these studies suggest that CD207+ LCs are only a minor
component of the antigen-presenting cell population that migrates from the epidermis and they are unlikely to be important in the prim-
ing of protective CD4+ cells in the sdLN.
 2006 Australian Society for Parasitology Inc. Published by Elsevier Ltd.
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Schistosomiasis is a parasitic disease aﬀecting over 200
million people in many parts of the developing world but
as yet an eﬀective vaccine has not been developed. Infection
of the mammalian host occurs by penetration of the skin0020-7519  2006 Australian Society for Parasitology Inc. Published by Elsev
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Once infective cercariae locate host skin, they enter the
stratiﬁed epidermis, aided by the secretion of enzymes from
the parasites’ acetabular glands (Salter et al., 2002). The
schistosome larvae then move through the skin until they
reach the epidermal–dermal basement membrane, which
acts as a barrier prior to their entry into the dermis.
Although the timing of parasite migration through the skin
is not agreed (McKerrow and Salter, 2002; Curwen and
Wilson, 2003), studies in the mouse suggest that penetra-
tion of the epidermis occurs within 30 min and the majorityier Ltd. Open access under CC BY license.
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Wilson, 1979). The parasites then exit the skin via blood
venules or lymphatic vessels, en route to the lungs and then
the blood vessels of the hepatic portal system (Schistosoma
mansoni) or the bladder vesical plexus (S. haematobium).
Irrespective of the ﬁnal site of parasitisation, a skin
phase of migration is common to all species of schisto-
somes and can be analysed eﬀectively using a murine model
(Stirewalt, 1974). Although penetration of the skin usually
only elicits transient dermal inﬂammation (Incani and
McLaren, 1984; Hogg et al., 2003a), repeated exposure
can result in cercarial dermatitis, which in the case of avian
schistosomes is characterised by a Th2-associated immedi-
ate hypersensitivity reaction (Kourilova et al., 2004). Nev-
ertheless, the skin also provides a logical site to target in the
development of an anti-larval vaccine (Mountford and
Trottein, 2004). In this context, radiation-attenuated
(RA) S. mansoni cercariae consistently elicit high levels of
protection characterised by the induction of Th1-associat-
ed immune responses (Hewitson et al., 2005). Analysis of
the skin exposure site after vaccination reveals focal inﬂam-
matory reactions composed of a heterogeneous array of
inﬁltrating leukocytes orchestrated by a cascade of chemo-
kines and cytokines (Riengrojpitak et al., 1998; Hogg et al.,
2003a,b). Signiﬁcantly, secretion of IL-12p40 by in vitro-
cultured skin biopsies from vaccinated mice was more sus-
tained compared with its transient production by skin
biopsies from mice exposed to normal (non-irradiated) lar-
vae (Hogg et al., 2003a). Of those cells that had the capac-
ity to migrate from the skin to the skin-draining lymph
nodes (sdLNs) many were MHCII+. Moreover, the major-
ity of the dermal exudate cells (DECs) that were positive
for intracellular IL-12p40 also expressed surface CD11c
and/or F4/80, indicating that they were dendritic cells
(DCs) and/or macrophages (Hogg et al., 2003a).
The fact that a large proportion of larvae remain in the
epidermis for greater than 24 h, and that cells with the
potential for antigen-processing presentation (i.e. were
MHCII+) migrated from the skin, raised the question as
to whether epidermal Langerhans cells (LCs) were a signif-
icant feature of the dermal immune response leading to the
induction of protective immunity by RA schistosomes. Epi-
dermal LCs are eﬃcient antigen-presenting cells (APCs) in
that they capture foreign antigens and process them into
antigenic fragments (Romani et al., 2003). They also
acquire the ability to migrate and so can transport antigen
to the sdLN where initiation and diﬀerentiation of the
adaptive T-cell response occurs (Schuler and Steinman,
1985; Steinman and Swanson, 1995). Although LCs share
a number of surface markers/receptors with other APCs
including DCs (e.g. CD11c), a transmembrane lectin
named langerin (CD207) unique to LCs was recently dis-
covered (Valladeau et al., 2000). CD207 is abundantly
expressed by epidermal LCs and freshly isolated LCs but
is down-regulated upon stimulation via CD40 and in vitro
culture (Valladeau et al., 2002; Stoitzner et al., 2003). It is
also an important marker to enable the tracking of LCmigration and distinguishing them in the sdLN where sev-
eral diﬀerent populations of DCs are present (Salomon
et al., 1998; Henri et al., 2001; Stoitzner et al., 2003). In this
manner, we can determine the importance of LCs relative
to other dermal DCs in initiation of the immune response
to schistosome antigens in the sdLN.
In the context of parasite infection, LCs may be an
important APC in the development of cutaneous immunity
to Leishmania major (Moll et al., 1993; Moll, 2003), since
LCs carry a substantial load of L. major promastigotes
(Baldwin et al., 2004), and Leishmania-exposed LCs are
thought to be the major cell type responsible for the pro-
duction of functional IL-12 (von Stebut et al., 1998). More-
over, LCs directly transport ingested L. major from the site
of infection to the T-cell areas of sdLN (Arnoldi and Moll,
1998), although others have more recently questioned the
relative importance of LCs in the priming of acquired
immunity against L. major (Filippi et al., 2003; Lemos
et al., 2004; Ritter et al., 2004). The parasitic helminth Bru-
gia malayi also induces the migration of LCs from human
epidermis (Semnani et al., 2004). In contrast, little is known
about how LCs respond to cutaneous schistosome infec-
tion. Recently, schistosomes were shown to delay the
migration of LCs (deﬁned as MHCII+) from the skin, med-
iated by PGD2 produced by parasites themselves (Angeli
et al., 2001). However, it is not known whether LCs play
a signiﬁcant role in the priming of the Th1-acquired
response to the well studied RA schistosome vaccine in
the mouse, although LCs have been implicated in the
induction of protection in a guinea pig model (Sato and
Kamiya, 1995).
In the present study, we used an antibody against
CD207 (Stoitzner et al., 2003), speciﬁcally to track LC
migration from the epidermis to the sdLN following percu-
taneous exposure of mice to RA schistosome larvae. We
report for the ﬁrst time that schistosomes induce the migra-
tion of CD207+ LCs from the epidermis to the sdLN but in
this site they represent only a minor population of skin-de-
rived APCs after schistosome exposure.
2. Materials and methods
2.1. Host and parasite
Anaesthetised female C57BL/6 strain mice (8–10 weeks
old) were exposed to between 200 and 500 optimally irradi-
ated (20-krad; 60Co source) or normal (non-irradiated)
cercariae of S. mansoni via each pinna as described previ-
ously (Mountford et al., 2001).
2.2. Preparation of tissues
The skin site of exposure and the sdLN (auricular) were
obtained from groups of mice at 0, 8, 16 and 24 h, and on
days 2, 4 or 8 after parasite exposure. Tissues were pre-
pared for histology, culture in vitro, or analysis by ﬂow
cytometry as described below. For conventional histology,
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10% buﬀered formalin) were stained with H&E. For immu-
nohistological analysis, pinnae and the sdLN were embed-
ded in OCT compound (H&E Ltd., Nottingham, UK) and
snap frozen in 2-methylbutane on liquid N2. Cryosections
were then cut (7–14 lm; Leica Microsystems cryostat, Ger-
many) and placed on poly-L-lysine-coated glass slides
(Superfrost Plus; Invitrogen, Paisley, UK) before ﬁxing in
3.7% paraformaldehyde. Epidermal sheets were obtained
by splitting pinnae and ﬂoating them on 0.5 M ammonium
thiocyanate in PBS at 37 C for 30 min (Gunn et al., 1999).
The sheets were then peeled from the underlying dermis
and rinsed in PBS prior to ﬁxing in 3.7% paraformaldehyde
on ice for 15 min.
For analysis of cells either on cytospins or by ﬂow
cytometry, single suspensions were obtained as follows.
Epidermal cells were isolated by ﬂoating split pinnae on
0.8% trypsin-PBS (Roche Applied Science, Germany) in
24-well culture plates (Nalgene, Nunc) at 37 C for
30 min (Koch et al., 1992; Stoitzner et al., 2003). Trypsin
digestion was stopped with RPMI medium containing
low endotoxin 10% FCS (Seralab, Oxon.UK), 2 mM L-glu-
tamine, 200 U/ml penicillin and 100 mg/ml streptomycin
(RPMI/10). The epidermal sheet was then removed, dis-
rupted on a vortex mixer for 10 s to break up the cell aggre-
gates and then ﬁltered through steel gauze to yield a single
cell suspension.
Cells that emigrate from the skin (DEC) were isolated as
described previously (Mountford et al., 2001; Hogg et al.,
2003a,b). Brieﬂy, pinnae were split and ﬂoated on 0.5 ml
RPMI/10 in 24-well hydrophobic culture plates (Greiner
Labortechnik, Frickenhausen, Germany) for 18 h at
37 C in 5% CO2. Cells which spontaneously detach from
the split pinnae were harvested, enumerated and resus-
pended in PBS containing 0.5 mM CaCl2, 0.5 mM MgCl2
and 0.1% BSA. The sdLN were digested with collagenase
D (0.5 mg/ml; Roche, Germany)/DNAse (0.02 mg/ml; Sig-
ma) at room temperature for 20 min (Wang et al., 1999)
and the stromal fragments disrupted before treating with
0.5 mM EDTA for 5 min to disrupt DC-T cell complexes.
2.3. Antibodies
Rat anti-mouse Langerin mAb (clone F929F3, rat IgG;
provided by Dr. Saeland, Schering-Plough, Dardilly,
France) was used to identify CD207+ LCs (Valladeau
et al., 2002; Stoitzner et al., 2003) followed by goat anti-
rat Ig conjugated with Alexaﬂuor 488 (MolecularProbes,
Leiden, The Netherlands) or Allophycocyanin (Caltag-
Medsystems, Towester, UK). This primary mAb speciﬁcal-
ly reacts with cytoplasmic epitopes of CD207, therefore
immunolabeling was performed using an intracellular
staining protocol including 0.1% saponin at each incuba-
tion step. To stain cell surface markers, biotinylated anti-
bodies were as follows: anti-CD4 (clone H129.19
Pharmingen, BD Biosciences), anti-MHC II (I-ab,d, clone
B21.2, Caltag-MedSystems) or anti-CD11c (clone HLA-3,Pharmingen) followed by streptavidin-conjugated Texas-
Red (Vector Laboratories, Peterborough, UK), APC or
ﬂuorescein isothiocyanate (FITC) (Caltag MedSystems).
Appropriate isotype-matched non-speciﬁc antibodies were
used throughout to establish control level background
staining. Parasites in the skin were localised using a
polyclonal rabbit antiserum against solubilised schistosome
larvae (Mountford et al., 1995) and probed using goat
anti-rabbit antibody conjugated to Alexa 594 (Molecular
probes).
2.4. Immunoﬂuorescent staining
Fixed sections of pinnae and sdLN or epidermal sheets
were ﬁrst treated with Avidin–Biotin blocking kit (Vector
Labs) to block non-speciﬁc binding due to endogenous bio-
tin. Sections were subsequently incubated with relevant pri-
mary unlabelled, or biotin-labelled antibodies, as described
above, alongside irrelevant isotype-matched control anti-
bodies. Tissue sections were then probed as appropriate
with ﬂuorescent-conjugated streptavidin, or secondary
mAbs prior to mounting with VectorShield (Vector Labs).
Alternatively, aliquots of relevant cell suspension were
spun at 500 rpm for 5 min (Cytospin 2, Shandon, UK)
and labelled as above for CD207 and MHCII.
2.5. Skin sensitisation with FITC
Naı¨ve mice were painted with 25 ll 1% FITC (Sigma)
preparation dissolved in 1:1 acetone:dibutylphalate (Sig-
ma) on the dorsal side of both ears, or with control vehicle
only (acetone:dibutylphalate). Tissues were removed at
24 h for analysis.
2.6. Analysis of cells in tissue sections
Tissue sections were viewed using a Nikon Labophot
ﬂuorescent microscope (Nikon Corp, Tokyo, Japan) and
photographed using a Nikon Coolpix 995 (Nikon Corp)
with subsequent analysis performed with Adobe Photo-
shop version 6. Confocal images were acquired on a Zeiss
Axiovert 200 M with an LSM 510 META system. All mul-
ticolour samples were imaged sequentially and controls
showed no bleed-through. Images were collected using
the LSM 510 software v3.2 and copied using Zeiss Image
Browser. The number of CD207+ cells was determined
per image, the frequency was converted to LC/mm2 and
the results expressed as mean + SEM of a minimum of
10 images.
2.7. Flow cytometric analysis of LCs in epidermal, dermal
exudate and sdLN cell suspensions
Aliquots of up to 5 · 105 cells from the epidermis, DEC
and sdLN were brieﬂy ﬁxed in 1% formaldehyde in PBS
and then permeabilised with 0.1% saponin in PBS contain-
ing 2% FCS. Cells were blocked with 2 ll rabbit IgG
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above. To label surface markers, CD207-stained cells were
washed twice with saponin-free PBS plus 2% FCS before
an excess of rat IgG (Sigma) was added to block residu-
al-free antibody binding sites (Stoitzner et al., 2003). Cells
were then labelled with phycoerythrin conjugated anti-
MHCII+ (M5/114.15.2, PharMingen) or anti-CD11c
mAb. Phenotypic data were acquired using a Cyan ﬂow
cytometer (Dakocytomation, UK) and analysed with Sum-
mit software.2.8. Statistics
Data were compared using the Student’s t test. (***,
P < 0.001; **, P < 0.01; *, P < 0.05; non-signiﬁcant,
P > 0.05). Arithmetic means ± SEM are shown. Data
shown are representative of two to four experimental
repeats.3. Results
3.1. LCs are present in the epidermis but at reduced numbers
after parasite exposure
Analysis of epidermal sheets of naı¨ve mice probed with
anti-CD207 mAb speciﬁcally revealed the presence of LCs
with a characteristic dendritic morphology (Fig. 1b and c).
The cells were evenly distributed throughout the epidermal
sheet with the dendrites reaching out to access most of the
tissue area. CD207+ LCs were distributed along the supra-
basal layer of the epidermis but not within the dermis of
naı¨ve mice as observed in transverse sections through the
mouse pinna (Fig. 1d and e). All of the CD207+ cells wereFig. 1. Localisation of CD207+ cells on epidermal sheets (a–c and f) and trans
IgG control (a), rat anti-CD207 probed with anti rat Alexaﬂuor 488 (green; b
Scale bars indicate 10 lm. Key: e, epidermis; d, dermis; c, cartilage.also positive for surface MHC II (Fig. 1f). However, while
CD207 was observed even in the remote thin part of the
dendrites, MHC II molecules were sparse in the cell
extremities and tended to be concentrated around the main
cell body.
Upon visual enumeration of CD207+ cells in epidermal
sheets of mice exposed to RA larvae, there were 40% fewer
cells on day 4 compared with naı¨ve controls (day
4 = 270 ± 33 cf. day 0 = 454 ± 77; P < 0.05, data not
shown). However, due to concerns about the subjectivity
of LC enumeration in epidermal sheets, cell suspensions
of the epidermis were also analysed by ﬂow cytometry. In
naı¨ve tissues, approximately 2% of the total epidermal cell
population was identiﬁed as CD207+MHCII+ (Fig. 2a and
b); there were no CD207+MHCII cells detected. Howev-
er, although the proportion of CD207+MHCII+ cells did
not change at 8, 16 or 24 h, a signiﬁcant 32% decrease
(P < 0.05) was detected at 48 h when the LCs comprised
only 1.4% of the total epidermal cell suspension (Fig. 2b).
The expression of MHCII on CD207+ epidermal cells
increased signiﬁcantly within 1 day of vaccination
(Fig. 2c) and remained signiﬁcantly elevated out to day 4,
although the level was declining to that detected in naı¨ve
mice. The decrease in the number of CD207+ cells in the
epidermis followed an increase in the thickness and cellu-
larity of both the epidermis and dermis at times when par-
asites were still present in the epidermis (Fig. 2d).3.2. CD207+ LCs emigrate from the epidermis after parasite
exposure
The DEC population that spontaneously migrated from
pinna biopsies during in vitro culture comprised a substan-verse sections of naı¨ve mouse pinna (d and e). Cells were labelled with rat
–f) and biotinylated anti-MHCII probed with streptavidin Texas-Red (f).
Fig. 2. CD207+ cells in epidermis at times after vaccination. (a) Representative
ﬂowcytogramofCD207+MHCII+cells inepidermal cell suspensionsat time0. (b)
The proportion of CD207+MHCII+ cells at times 0, 8, 16, 24 and 48 h post
vaccination,asdeﬁnedbyﬂowcytometricanalysis.Horizontaldotted line indicates
thevalue innaı¨ve (day0)mice *P < 0.05. (c)Relative expression levelofMHCIIon
CD207+MHCII+cells shownasthemeanﬂuorescence intensity(MFI)atdays0,1,
2 and 4. Bars are means of three to six pinnae ± SEM **P <0.01. (d) Location of
parasites (arrowed) in the pinnae at 24 and 48 h showing increased cellularity of
bothepidermis anddermis. Scale bar indicates 50 lm.Key: e, epidermis; d, dermis.
ig. 3. CD207+ cells in the dermal exudate population after vaccination.
a) Dermal exudate cell (DEC) numbers are shown for total (solid line),
D207MHCII+ (dashed line) and CD207+MHCII+ (dotted line) cells at
ays 0, 1, 2 and 4. Lines are means of DEC populations from individual
ice (n = 4), ±SEM. Signiﬁcance is for the number of cells at times after
accination compared with time 0. (b) Relative expression level of MHCII
n CD207+MHCII+ DEC (open bar) and CD207MHCII+ DEC (cross-
atched bar) shown as the mean ﬂuorescence intensity (MFI) of MHCII
taining on days 0, 1, 2 and 4. Bars represent mean of DEC from
accinated mice (n = 3) ± SEM. Signiﬁcance values are for CD207+ or
D207 cells at diﬀerent days compared with day 0 *P < 0.05, **P < 0.01.










Ctial number of MHCII+ cells but only a minority were also
positive for intracellular CD207 (Fig. 3a). Between
15.1 ± 0.86% (day 2), 25.1 ± 1.51% (day 4) and
32.4 ± 2.83% (day 8) of the DEC population were MHCII+
but less than 1% (0.29–0.57%) of the total were CD207+.
However, all CD207+ cells were MHCII+ since no
CD207+MHCII cells were detected at any time point.
Multiplication of these percentages by the total number of
cells recovered at diﬀerent times after vaccination show that
the number of CD207MHCII+ and CD207+MHCII+
DECs increased signiﬁcantly by day 1 (both P < 0.01;
Fig. 3a). This was followed by a consistent increase in both
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CD207MHCII+ cells in the DEC population was about
15-fold greater than the number of CD207+MHCII+ cells
at all times (P < 0.01–0.001). There is a hint that the extent
of MHCII expression on migrating CD207+MHCII+ cells
increases after vaccination (i.e. day 1 cf. day 0) but this
was not signiﬁcant (Fig. 3b). In comparison, the level of
expression of MHCII on CD207MHCII+ cells decreases
signiﬁcantly on days 1 and 2 post vaccination (Fig. 3b).
Therefore, CD207+ cells appear to have the potential to
be better APCs than CD207 cells, although they appear
much less frequently (Fig. 3a).
Histological examination of CD207+ cells in the dermal
tissue conﬁrmed that while they were found exclusively in
the epidermis of naı¨ve mice (Fig. 1d and e), a small number
were observed in the dermis on days 2 (Fig. 4b) and 4
(Fig. 4c and d) post vaccination. A schistosome larva
observed in the epidermis on day 2 is associated with
CD207+ cells in the underlying region of the dermis
(Fig. 4a and b). CD207+ cells were also evident in the epi-
dermis but were absent in the immediate vicinity of the par-
asite. CD207+ cells in the dermis tended to be observed in
groups and were not evenly scattered, suggesting a focal
response to parasite exposure (Fig. 4c and d). There was
evidence that the number of CD207+ cells in the epidermis
immediately adjacent to the groups of dermal-located cells
was reduced but this was not possible to enumerate. The
scarce presence of CD207+ cells in the DEC population
(Fig. 3a) was conﬁrmed visually by staining of DECs on
cytospins revealing occasional CD207+ cells (Fig. 4e and
f), which were always MHCII+ but most MHCII+ DEC
were not CD207+ (Fig. 4g). Visual enumeration of
CD207+ cells in the dermis shows there to be over 5-foldFig. 4. Emigration of CD207+ cells into the dermis. Transverse section of pin
epidermis. Confocal image of the same section (b) showing CD207+ cells (gree
CD207+ cells in the dermis on day 4. Cytospins of dermal exudates cell (DE
majority of DECs (g) are MHCII+ (red) and only a minority are CD207+ (gr
dermis (h) of naı¨ve mice or on day 4. Signiﬁcance values are for day 4 cf. daymore cells in the dermis on day 4 after vaccination than
in naı¨ve mice (P < 0.01; Fig. 4h).
3.3. CD207+ cells selectively accumulate in lymph nodes
draining inﬂamed skin
Of the three peripheral lymph nodes (LNs) located in
the neck/throat region, only the auricular LN contained
CD207+ cells (Fig. 5a and b). Virtually no CD207+ cells
were observed in the adjacent cervical and axillar LN, or
the distant mesenteric LN draining the large intestine (data
not shown). Signiﬁcantly, CD207+ cells were restricted to
the T-cell zone in the inner paracortical areas and none
were found in the B cell follicles of the marginal cortex
(Fig. 5a). At higher magniﬁcation, CD207+ cells can be
observed with extended processes in close apposition to
CD4+ cells in the T-cell zone (Fig. 5a inset). The overall
increase in the number of cells in the sdLN after vaccina-
tion was mirrored by a signiﬁcant increase in the number
of CD207+MHCII+ cells by days 2 and 4 (P < 0.05;
Fig. 5b). An increase in the number of CD207+MHCII+
cells was also apparent by day 1, although this was not sta-
tistically signiﬁcant. The proﬁle of CD207+MHCII+ cell
numbers was similar to the increase in the overall number
of CD207MHCII+ cells which were 8-fold (day 1) to 26-
fold (day 4) more abundant.
3.4. Dermal APCs are preferentially recruited to the sdLN
after sensitisation
Since the number of CD207+ cells recruited to the sdLN
after parasite exposure seemed very limited, we made a
comparison with cell migration following a conventionalna on day 2 (a) shown under bright ﬁeld demonstrating a parasite in the
n) in relation to the parasite (red). Focal grouping (c and d) of emigrating
C) population under (e) phase contrast and (f) stained for CD207. The
een). Scale bars = 25lm. Mean number ± SEM of CD207+ cells per mm2
0 *P < 0.05.
Fig. 5. CD207+ cells are induced to migrate to the skin-draining lymph
node (sdLN) after vaccination. (a) CD207+ cells (green) are located in
CD4+ cell (red) rich inner paracortical areas of the sdLN (200·
magniﬁcation). (Inset) Close up view of CD207+ cells in close contact
with CD4+ cells (600·). Key: C, LN capsule; B, B cell zone/germinal
centre in marginal cortex; T, T cell zone in the inner paracortical region.
(b) Numbers of total (solid line), CD207MHCII+ (dashed line) and
CD207+MHCII+ (dotted line) cells in the sdLN at days 0, 1, 2 and 4 post
vaccination. Lines are means of sdLN populations from individual mice
(n = 4), ±SEM. Signiﬁcance values are for cell numbers at days after
vaccination compared with day 0 *P < 0.05, **P < 0.01.
Fig. 6. Relative migration of CD207+, CD11c+ and MHCII+ cells to the
skin-draining lymph node (sdLN) after skin priming. Migration of
Langerhans cells (CD207+MHCII+ or CD207+CD11c+), dermal dendritic
cells (CD207CD11c+) and other antigen-presenting cells
(CD207MHCII+) into the sdLN (a and b) 24 h after sensitising the
epidermis with ﬂuorescein isothiocyanate (FITC) (hatched bar) versus
empty vehicle control (open bar), or (c and d) 48 h after exposure to
vaccinating parasites (shaded bars) versus naı¨ve (open bar). Bars are
means of sdLN (n = 4), ±SEM.
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(Douillard et al., 2005; Kissenpfennig et al., 2005). To
increase the sensitivity of detection, the percent-positive
events were gated to the largest and most granular cells
(LGC; represents approximately 10% of the total sdLN cell
pool). By day 1 after painting the epidermis with FITC, the
proportion of MHCII+ LGC that were CD207+ doubled
from 2.3% in mice painted with control vehicle only, to just
over 5% (Fig. 6a). The proportion that were CD207
increased 3-fold from 7.3% to over 20%. By comparison,
after parasite exposure the proportion of MHCII+ LGCs
that were CD207+ increased only 1.5-fold from 1.6% to
2.5%, and the proportion of CD207 cells increased by just
1.9-fold to 15.3% (Fig. 6c).
A similar picture emerges from analysis of cells probed
with the conventional DC marker CD11c (Fig. 6b). The
proportion of CD207+ cells increased by 2.2-fold to 3.6%in the sdLN of mice painted with FITC, while the propor-
tion of CD207 cells which will be dermal DCs (not LCs)
increased 2.7-fold to over 7%. In comparison, the propor-
tion of CD207+CD11c+ cells in the sdLN of mice exposed
to schistosome larvae only increased by 1.1-fold to 3.1%
but the proportions of CD207CD11c+ cells again
increased by 4-fold to reach over 7% (Fig. 6d).
3.5. Migration of LCs in response to RA and normal
schistosomula
Since RA schistosome larvae exhibit retarded migration
from the skin compared with normal larvae (Mountford
et al., 1988), it is possible that the emigration of CD207+
LCs from the skin to the sdLN in response to these two
forms of parasite diﬀers. A reduction in the CD207+ cell
population in the epidermis was evident by 48 h following
exposure to RA larvae (Fig. 2a). However, in a direct com-
parative analysis, the numbers of CD207+ cells observed in
the epidermis following exposure to normal and RA larvae
were shown to be similar and not signiﬁcantly diﬀerent
(P > 0.05; Fig. 7a). In this experiment, signiﬁcantly reduced
numbers of epidermal CD207+ cells were apparent only by
day 4 (P < 0.01); the reduction was still evident by day 8
after parasite exposure in both groups of mice.
Analysis of the CD207+ population in the sdLN
revealed that both RA and normal larvae initiated similar
changes to the proportions of CD207+MHCII+ cells at
all time points. This equated to between 2% and 3% of
the large granular cell population as noted earlier
(Fig. 6a). However, when the cellularity of the sdLN in
the two groups of mice was taken into account, it became
evident that the number of LCs in the sdLN of mice
Fig. 7. Migration of CD207+MHCII+ cells out of the epidermis into the
skin-draining lymph node (sdLN) of vaccinated and infected mice. (a)
Proportion of CD207+MHCII+ cells in the epidermal cell suspension and
(b) total numbers in the sdLN on days 0, 1, 2, 4 and 8 p.i. (open) or after
vaccination (shaded). Bars are means of sdLN (n = 4), ±SEM. Horizontal
line is the value in naı¨ve mice. Signiﬁcance is for the diﬀerence in
vaccinated compared with infected mice *P < 0.05.
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the sdLN of mice exposed to RA larvae on day 2
(P < 0.05; Fig. 7b). The number of CD207+MHCII+ in
mice immunised with RA larvae was only greater than in
infected mice by day 8, although this diﬀerence was not
signiﬁcant.4. Discussion
For the ﬁrst time to our knowledge, we show that schis-
tosome larvae induce the migration of CD207+ LC from
the site of immunisation to the sdLN. However, although
LCs have the potential to be important antigen-processing
and -presenting cells, the limited numbers of migrants in
the context of a substantial antigenic insult (i.e. the immun-
ising larvae) makes it unlikely that they have a dominant
role in priming the early CD4+ immune response in the
draining lymphoid tissue.
Using the rat mAb F929F3 which speciﬁcally recognises
a cytoplasmic epitope of CD207 (langerin; Valladeau et al.,
2002), we conﬁrm that LCs are a relatively common cell
within the epidermis and they form an evenly distributed
network across the epidermal surface (Valladeau et al.,
2002; Stoitzner et al., 2003). Although LCs express other
surface antigens (e.g. MHCII, CD205 and CD11c), these
are also expressed by other cell types such as DCs and mac-
rophages, and only CD207 is restricted to LCs. LCs have
been reported to occur in a ratio of 1:15 relative to kerati-
nocytes (Mulholland et al., 2006); in the present study
using ﬂow cytometric enumeration, the CD207+ cell popu-lation of the naı¨ve epidermis appeared to be less frequent,
being approximately 2% of the total epidermal cell popula-
tion. In our immunohistochemical studies, CD207+ cells
locate in the suprabasal layer of the epidermis, above the
epidermal basement membrane which also acts as a barrier
to onward parasite migration (Wheater and Wilson, 1979).
Indeed, multi-photon imaging of LCs positions them
approximately 3 lm above the basement membrane (Mul-
holland et al., 2006), ideally located to come into contact
with schistosome larvae. We conﬁrmed that all CD207+
cells in the epidermis are also MHCII+. Interestingly, the
relative level of MHCII expression by CD207+ cells in
the epidermis is enhanced after vaccination, probably in
response to acute phase cytokines such as IL-1b which
we know is released soon after vaccination (Hogg et al.,
2003a). This reinforces the notion that they could be eﬃ-
cient antigen-processing cells with the ability to present
antigen. The dendrites of the LC population can be seen
to extend across and access virtually the entire epidermal
layer acting as a well-placed sentinel to detect and pick
up antigens from incoming pathogens. The dendrites are
thought to exhibit dSEARCH (dendrite surveillance exten-
sion and retraction cycling habitude) activity and the cells
can also move laterally in response to inﬂammatory stimuli
(Nishibu et al., 2006). Therefore, the intricate network of
LCs in the epidermis should be able to detect most, if not
all, of the percutaneously applied schistosome larvae used
to immunise the murine host in our studies. Indeed, the
much greater size of schistosome larvae makes it highly
likely that they would come into contact with at least one
LC.
Exposure of the skin to S. mansoni larvae induced the
migration of some CD207+ cells from the epidermis within
24 h, which was conﬁrmed by histological examination of
the immunisation site, demonstrating that limited numbers
of CD207+ cells migrate from the epidermis into the under-
lying dermis. The migratory response of CD207+ cells
appeared to be focal with cells detected as groups in the
dermis rather than as an even scatter. In sections where a
parasite was detected at the epidermal basement membrane
(e.g. at day 2), the CD207+ cells were located ‘downstream’
of the parasite and it is probable that these cells were
migrants on their way to dermal lymphatic vessels leading
to the sdLN. There was no evidence that CD207+ cells
migrate laterally towards schistosomes since, rather than
an accumulation, there was a relative absence in the imme-
diate vicinity of epidermally located parasites. In tissue sec-
tions where a parasite was not detected, groups of CD207+
cells were also detected in the dermis. This might be due to
the parasite having already left the skin site or the parasite
had migrated out of the plane of view. Microscopy studies
of living tissues using multi-photon technology should
establish the precise inter-relationship of LCs and parasites
in the epidermis.
Analysis of the number of CD207+ cells in the epidermis
initially supports the notion of parasite-induced migration
of LCs from the epidermis since fewer were counted in
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ﬂow cytometric enumeration of digested epidermal cell sus-
pensions revealed that the number of CD207+ cells only
declined in the epidermis by days 2–4 and the numbers
detected within the ﬁrst 48 h were similar to those in naı¨ve
mice. In this respect, it is possible that CD207is down-reg-
ulated by inﬂammatory stimuli such as lipopolysaccharide
and ligation of CD40 (Takahara et al., 2002), such that
LCs are no longer identiﬁed as CD207+ and might be
underestimated, but this could be just a feature of in vitro
culture (Stoitzner et al., 2003). On the other hand, CD207
is believed to be expressed during the migration of LCs
(Kamath et al., 2002; Stoitzner et al., 2003) and character-
ises mature rather than immature LCs (Valladeau et al.,
2000). The phenomenon of LC migration blockade follow-
ing exposure to S. mansoni was originally reported by
Angeli et al. (2001). They showed that the migration of epi-
dermal LCs identiﬁed only by the expression of MHCII+
was inhibited following schistosome infection; this was
transient and mediated by the production of parasite-de-
rived prostaglandin D2 which speciﬁcally disrupted
TNFa-induced migratory potential (Angeli et al., 2001).
Furthermore, the active parasite component was later
described to be a molecule with glutathione-S-transferase
activity by acting on the D prostanoid receptor 1 (Herve
et al., 2003). In part, our studies support the reported inhi-
bition of LC migration following parasite exposure. How-
ever, through use of the anti-CD207 mAb as a speciﬁc
marker for LCs, as distinct from other dermal-derived
MHCII+ cells, we are also able to show that some LCs
are able to migrate out of the epidermis within the ﬁrst
48 h and begin to accumulate in the sdLN as early as
24 h after parasite exposure. Combined, our results suggest
that the total number of LCs increases after parasite expo-
sure, possibly from a population of Gr-1hi+ monocytes
(Ginhoux et al., 2006), and that while some are retained
in the epidermis, a proportion successfully leave within
the ﬁrst 24–48 h and migrate via the dermis to accumulate
in the sdLN. Another conclusion that might be made from
our results, is that migrating CD207+MHCII+ DECs
express greater amounts of MHCII after vaccination than
CD207MHCII+ DECs. This suggests that migrating
CD207+ LCs have a greater capacity to eﬃciently present
antigen upon arrival at the draining LN than migrating
CD207 cells, such as dermal DCs or macrophages.
The detection of CD207+ cells in the sdLN of naı¨ve mice
was at ﬁrst surprising but the staining was clearly speciﬁc
since CD207+ cells were not observed in other LNs such
as the mesenteric LN. This supports the view that the
CD207+ cells in the sdLN observed in our studies were
not the minor subset of lymphoid origin recently identiﬁed
as CD11chi, CD8a+, CD11blo which can be located in the
mesenteric LN and spleen; rather they are of the CD11clo,
CD8alo, CD11bhi subset of epidermal origin (Douillard
et al., 2005). The presence of CD207+ cells in substantial
numbers in the sdLNs of naı¨ve mice most likely reﬂects
their traﬃc under normal conditions in the absence of aninﬂammatory stimulus (Stoitzner et al., 2005). Neverthe-
less, elevated numbers of CD207+MHCII+ cells were clear-
ly detected in the sdLN after parasite exposure which
progressively increased by day 4. Although this increase
was marked, it was overshadowed by a far greater increase
in the numbers of MHCII+ cells that were CD207.
Indeed, the number of MHCII+CD207 cells were 10 times
more frequent than CD207+ cells; this does not just reﬂect
a proportionally greater increase of MHCII+ B lympho-
cytes in the sdLN but also an increase in CD207CD11c+
cells which increased 16-fold compared with a 3.1-fold
increase in CD207+CD11c+ cells. The increase in cells with
APC function is likely to be cells originating from the skin
in response to signalling via CCR7 (Ohl et al., 2004) but it
is clear that only a small proportion are classical CD207+
LCs. The majority of APCs are likely to be macrophages
and CD11c+ DCs, since both are abundant components
of the dermis (Dupasquier et al., 2004). Our data compar-
ing the migration of CD207+ and CD207 cells in response
to a contact sensitising agent (FITC) or RA schistosome
larvae, support the view that, under inﬂammatory condi-
tions, MHCII+ macrophages and/or dermal DCs are the
most abundant cells to migrate from the skin to the sdLN
and that CD207+ LCs are only a minor constituent despite
expressing greater levels of MHCII. This diﬀerence in cell
numbers may be a function of their relative migratory
dynamics since data accrued from intravital imaging of
LC migration in vivo using transgenic mice with the
enhanced green ﬂuorescent protein under the CD207 gene,
proposes that CD207+ LCs are slower to migrate to the
sdLN than dermal DCs (Kissenpfennig et al., 2005; Kis-
senpfennig and Malissen, 2006).
Although we have evidence that CD207+ and other cells
with APC function migrate from the skin to the sdLN, we
have no proof that they process parasite antigen in the skin
prior to departure or that they present the same antigen to
CD4+ cells in the sdLN. They may even cross-present anti-
gen to other APCs (Stoitzner et al., 2006) in the skin prior
to migration of the latter to the sdLN. Furthermore, both
parasites and parasite antigen drain directly to the sdLN
(Mountford et al., 1988) independent of any migrating
APCs, and antigen could be presented by resident APCs
in situ. Unfortunately, it has not yet proven possible to sta-
bly transfect invasive cercariae with a plasmid expressing
ﬂuorescent probe(s) to allow visual detection of antigen
uptake by MHCII+ cells. Another unresolved issue is
whether CD207+ LCs in the DEC population are IL-
12p40+ as originally proposed (Hogg et al., 2003a). We
have been unable to convincingly co-detect intracellular
IL-12p40 and intracellular CD207 using the currently
available mAbs (Gavin Jenkins, unpublished data). IL-12
production by LC may actually be down-regulated, as
reported to occur in susceptible strains of mice after
infection with L. major (Moll et al., 2002), although
intriguingly, ligation of CD154 on LCs is reported to
stimulate IL-12p40 production (Sugaya et al., 2005) and
may explain the up-regulation of IL-12p40 release by skin
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mice exposed to the RA schistosome vaccine (Hewitson
et al., 2006).
The rationale for analysing the migration of CD207+
LCs in our model of parasite immunisation was that LCs
would be important in the priming of a CD4+ mediated
immune response in the sdLN, which ultimately would lead
to the development of a protective immune response (Sato
and Kamiya, 1995; Hogg et al., 2003a; Hewitson et al.,
2005). Therefore, we compared the dynamics of CD207+
cell migration in mice exposed to protective RA larvae or
non-protective normal parasites. The vast majority of nor-
mal parasites exit from the skin by day 8, whilst nearly one
third of RA larvae remain (Mountford et al., 1988). How-
ever, no diﬀerence was determined in the rate of CD207+
cell migration out of the exposure site, despite the pro-
longed antigenic stimulus in the pinnae of vaccinated mice.
Similarly, no diﬀerence was observed in the proportion of
CD207+ cells between the sdLN from the two groups of
mice. Therefore, the presence of CD207+ cells in the sdLN
does not correlate with the previously reported enhanced
CD4+ cell proliferation and Th1 cytokine production that
is a feature of mice exposed to the RA schistosome vaccine
(Hogg et al., 2003b; Hewitson et al., 2005).
On the other hand, it is possible that CD207+ cells,
despite expressing slightly greater amounts of MHCII, do
not have an immune priming role but regulate events in
the sdLN, or cross-present antigen to other APCs (Stoitzner
et al., 2006). In certain viral infection models, CD8a+ der-
mal DCs and not LCs have the major antigen-presenting
function (Allan et al., 2003; Zhao et al., 2003). Moreover,
several studies of L. major infection undermine the role of
LCs as being responsible for priming the CD4+-mediated
acquired immune response and instead highlight the role
of dermal DCs (Filippi et al., 2003; Lemos et al., 2004; Rit-
ter et al., 2004). In this context, we recently reported that
molecules released by the invading schistosome larvae in
the ﬁrst few hours (i.e. equivalent to when the parasite is still
in the epidermis) activate bone-marrow-derived DCs to
become potent stimulators of Th2-type responses in vitro
and in vivo (Jenkins and Mountford, 2005). These mole-
cules may have an immunomodulatory function via their
constituent glycans through the ligation of toll-like receptor
4 leading to the production of IL-10 (Jenkins et al.,
2005a,b). Indeed, it is reported that B. malayi larvae act
on LCs to depress MHCII expression and gene transcripts
for cytokines associated with antigen presentation leading
to a decreased ability to prime CD4+ cells responses (Sem-
nani et al., 2004). It is therefore possible that CD207+ LCs
have an, as yet, unappreciated role in modulating the
immune response to schistosomes distinct from its pre-
sumed role as an APC. Indeed, recent observations on the
dynamics and functions of CD207+ cells fuel speculation
in a number of diﬀerent inﬂammatory situations that LCs
have a regulatory, rather than stimulatory, role (Itano
et al., 2003; Douillard et al., 2005; Villadangos and Heath,
2005; Kissenpfennig and Malissen, 2006).Acknowledgements
S.K. was supported by a PhD studentship awarded by
the Royal Thai Government. A.P.M. and G.R.J. were sup-
ported by the Wellcome Trust (# 056213 and 071762,
respectively); R.A.P. was in receipt of a PhD studentship
form the Biotechnology and Biological Sciences Research
Council of the UK. The following are thanked: Ann Bam-
ford for maintaining the parasite life cycle, Peter Cook for
experimental help and Peter O’Toole and Karen Chance of
the Imaging and Cytometry laboratories in the Department
of Biology.References
Allan, R.S., Smith, C.M., Belz, G.T., van Lint, A.L., Wakim, L.M.,
Heath, W.R., Carbone, F.R., 2003. Epidermal viral immunity induced
by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301,
1925–1928.
Angeli, V., Faveeuw, C., Roye, O., Fontaine, J., Teissier, E., Capron, A.,
Wolowczuk, I., Capron, M., Trottein, F., 2001. Role of the parasite-
derived prostaglandin D2 in the inhibition of epidermal Langerhans
cell migration during schistosomiasis infection. J. Exp. Med. 193,
1135–1147.
Arnoldi, J., Moll, H., 1998. Langerhans cell migration in murine
cutaneous leishmaniasis: regulation by tumor necrosis factor alpha,
interleukin-1 beta, and macrophage inﬂammatory protein-1 alpha.
Dev. Immunol. 6, 3–11.
Baldwin, T., Henri, S., Curtis, J., O’Keeﬀe, M., Vremec, D., Shortman,
K., Handman, E., 2004. Dendritic cell populations in Leishmania
major-infected skin and draining lymph nodes. Infect. Immun. 72,
1991–2001.
Curwen, R.S., Wilson, R.A., 2003. Invasion of skin by schistosome
cercariae: some neglected facts. Trends Parasitol. 19, 63–66.
Douillard, P., Stoitzner, P., Tripp, C.H., Clair-Moninot, V., Ait-Yahia, S.,
McLellan, A.D., Eggert, A., Romani, N., Saeland, S., 2005. Mouse
lymphoid tissue contains distinct subsets of langerin/CD207 dendritic
cells, only one of which represents epidermal-derived Langerhans cells.
J. Invest. Dermatol. 125, 983–994.
Dupasquier, M., Stoitzner, P., van Oudenaren, A., Romani, N., Leenen,
P.J., 2004. Macrophages and dendritic cells constitute a major
subpopulation of cells in the mouse dermis. J. Invest. Dermatol. 123,
876–879.
Filippi, C., Hugues, S., Cazareth, J., Julia, V., Glaichenhaus, N., Ugolini,
S., 2003. CD4+ T cell polarization in mice is modulated by strain-
speciﬁc major histocompatibility complex-independent diﬀerences
within dendritic cells. J. Exp. Med. 198, 201–209.
Ginhoux, F., Tacke, F., Angeli, V., Bogunovic, M., Loubeau, M.,
Dai, X.M., Stanley, E.R., Randolph, G.J., Merad, M., 2006.
Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7,
265–273.
Gunn, M.D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A.,
Williams, L.T., Nakano, H., 1999. Mice lacking expression of
secondary lymphoid organ chemokine have defects in lymphocyte
homing and dendritic cell localization. J. Exp. Med. 189, 451–
460.
Henri, S., Vremec, D., Kamath, A., Waithman, J., Williams, S., Benoist,
C., Burnham, K., Saeland, S., Handman, E., Shortman, K., 2001. The
dendritic cell populations of mouse lymph nodes. J. Immunol. 167,
741–748.
Herve, M., Angeli, V., Pinzar, E., Wintjens, R., Faveeuw, C., Narumiya,
S., Capron, A., Urade, Y., Capron, M., Riveau, G., Trottein, F., 2003.
Pivotal roles of the parasite PGD2 synthase and of the host D
prostanoid receptor 1 in schistosome immune evasion. Eur. J.
Immunol. 33, 2764–2772.
S. Kumkate et al. / International Journal for Parasitology 37 (2007) 209–220 219Hewitson, J.P., Hamblin, P.A., Mountford, A.P., 2005. Immunity induced
by the radiation-attenuated schistosome vaccine. Parasite Immunol.
27, 271–280.
Hewitson, J.P., Jenkins, G.R., Hamblin, P.A., Mountford, A.P., 2006.
CD40/CD154 interactions are required for the optimal maturation of
skin-derived APCs and the induction of helminth-speciﬁc IFN-c but
not IL-4. J. Immunol. 177, 3209–3217.
Hogg, K.G., Kumkate, S., Anderson, S., Mountford, A.P., 2003a.
Interleukin-12 p40 secretion by cutaneous CD11c+ and F4/80+ cells
is a major feature of the innate immune response in mice that develop
Th1-mediated protective immunity to Schistosoma mansoni. Infect.
Immun. 71, 3563–3571.
Hogg, K.G., Kumkate, S., Mountford, A.P., 2003b. IL-10 regulates early
IL-12-mediated immune responses induced by the radiation-attenuated
schistosome vaccine. Int. Immunol. 15, 1451–1459.
Incani, R.N., McLaren, D.J., 1984. Histopathological and ultrastructural
studies of cutaneous reactions elicited in naive and chronically infected
mice by invading schistosomula of Schistosoma mansoni. Int. J.
Parasitol. 14, 259–276.
Itano, A.A., McSorley, S.J., Reinhardt, R.L., Ehst, B.D., Ingulli, E.,
Rudensky, A.Y., Jenkins, M.K., 2003. Distinct dendritic cell popula-
tions sequentially present antigen to CD4 T cells and stimulate
diﬀerent aspects of cell-mediated immunity. Immunity 19, 47–57.
Jenkins, S.J., Hewitson, J.P., Ferret-Bernard, S., Mountford, A.P., 2005a.
Schistosome larvae stimulate macrophage cytokine production
through TLR4-dependent and -independent pathways. Int. Immunol.
17, 1409–1418.
Jenkins, S.J., Hewitson, J.P., Jenkins, G.R., Mountford, A.P., 2005b.
Modulation of the host’s immune response by schistosome larvae.
Parasite Immunol. 27, 385–393.
Jenkins, S.J., Mountford, A.P., 2005. Dendritic cells activated with
products released by schistosome larvae drive Th2-type immune
responses, which can be inhibited by manipulation of CD40 costimu-
lation. Infect. Immun. 73, 395–402.
Kamath, A.T., Henri, S., Battye, F., Tough, D.F., Shortman, K., 2002.
Developmental kinetics and lifespan of dendritic cells in mouse
lymphoid organs. Blood 100, 1734–1741.
Kissenpfennig, A., Henri, S., Dubois, B., Laplace-Builhe, C., Perrin, P.,
Romani, N., Tripp, C.H., Douillard, P., Leserman, L., Kaiserlian, D.,
Saeland, S., Davoust, J., Malissen, B., 2005. Dynamics and function of
Langerhans cells in vivo: dermal dendritic cells colonize lymph node
areas distinct from slower migrating Langerhans cells. Immunity 22,
643–654.
Kissenpfennig, A., Malissen, B., 2006. Langerhans cells – revisiting the
paradigm using genetically engineered mice. Trends Immunol. 27, 132–
139.
Koch, F., Kampgen, E., Schuler, G., Romani, N., 1992. Eﬀective
enrichment of murine epidermal Langerhans cells by a modiﬁed
(mismatched) panning technique. J. Invest. Dermatol. 99, 803–807.
Kourilova, P., Hogg, K.G., Kolarova, L., Mountford, A.P., 2004.
Cercarial dermatitis caused by bird schistosomes comprises both
immediate and late phase cutaneous hypersensitivity reactions. J.
Immunol. 172, 3766–3774.
Lemos, M.P., Esquivel, F., Scott, P., Laufer, T.M., 2004. MHC class II
expression restricted to CD8alpha+ and CD11b+ dendritic cells is
suﬃcient for control of Leishmania major. J. Exp. Med. 199, 725–730.
McKerrow, J.H., Salter, J., 2002. Invasion of skin by Schistosoma
cercariae. Trends Parasitol. 18, 193–195.
Moll, H., Fuchs, H., Blank, C., Rollinghoﬀ, M., 1993. Langerhans cells
transport Leishmania major from the infected skin to the draining
lymph node for presentation to antigen-speciﬁc T cells. Eur. J.
Immunol. 23, 1595–1601.
Moll, H., Scharner, A., Kampgen, E., 2002. Increased interleukin 4 (IL-4)
receptor expression and IL-4-induced decrease in IL-12 production by
Langerhans cells infected with Leishmania major. Infect. Immun. 70,
1627–1630.
Moll, H., 2003. Dendritic cells and host resistance to infection. Cell.
Microbiol. 5, 493–500.Mountford, A.P., Coulson, P.S., Wilson, R.A., 1988. Antigen localization
and the induction of resistance in mice vaccinated with irradiated
cercariae of Schistosoma mansoni. Parasitology 97 (Pt. 1), 11–25.
Mountford, A.P., Harrop, R., Wilson, R.A., 1995. Antigens derived
from lung-stage larvae of Schistosoma mansoni are eﬃcient stimula-
tors of proliferation and gamma interferon secretion by lymphocytes
from mice vaccinated with attenuated larvae. Infect. Immun. 63,
1980–1986.
Mountford, A.P., Hogg, K.G., Coulson, P.S., Brombacher, F., 2001.
Signaling via interleukin-4 receptor alpha chain is required for
successful vaccination against schistosomiasis in BALB/c mice. Infect.
Immun. 69, 228–236.
Mountford, A.P., Trottein, F., 2004. Schistosomes in the skin: a balance
between immune priming and regulation. Trends Parasitol. 20, 221–
226.
Mulholland, W.J., Arbuthnott, E.A., Bellhouse, B.J., Cornhill, J.F.,
Austyn, J.M., Kendall, M.A., Cui, Z., Tirlapur, U.K., 2006. Multi-
photon high-resolution 3D imaging of Langerhans cells and keratino-
cytes in the mouse skin model adopted for epidermal powdered
immunization. J. Invest. Dermatol. 126, 1541–1548.
Nishibu, A., Ward, B.R., Jester, J.V., Ploegh, H.L., Boes, M., Takashima,
A., 2006. Behavioral responses of epidermal Langerhans cells in situ to
local pathological stimuli. J. Invest. Dermatol. 126, 787–796.
Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J.,
Blankenstein, T., Henning, G., Forster, R., 2004. CCR7 governs skin
dendritic cell migration under inﬂammatory and steady-state condi-
tions. Immunity 21, 279–288.
Riengrojpitak, S., Anderson, S., Wilson, R.A., 1998. Induction of
immunity to Schistosoma mansoni: interaction of schistosomula with
accessory leucocytes in murine skin and draining lymph nodes.
Parasitology 117 (Pt. 4), 301–309.
Ritter, U., Meissner, A., Scheidig, C., Korner, H., 2004. CD8 alpha- and
Langerin-negative dendritic cells, but not Langerhans cells, act as
principal antigen-presenting cells in leishmaniasis. Eur. J. Immunol.
34, 1542–1550.
Romani, N., Holzmann, S., Tripp, C.H., Koch, F., Stoitzner, P., 2003.
Langerhans cells – dendritic cells of the epidermis. Apmis 111, 725–
740.
Salomon, B., Cohen, J.L., Masurier, C., Klatzmann, D., 1998. Three
populations of mouse lymph node dendritic cells with diﬀerent origins
and dynamics. J. Immunol. 160, 708–717.
Salter, J.P., Choe, Y., Albrecht, H., Franklin, C., Lim, K.C., Craik, C.S.,
McKerrow, J.H., 2002. Cercarial elastase is encoded by a functionally
conserved gene family across multiple species of schistosomes. J. Biol.
Chem. 277, 24618–24624.
Sato, H., Kamiya, H., 1995. Role of epidermal Langerhans’ cells in the
induction of protective immunity to Schistosoma mansoni in guinea-
pigs. Immunology 84, 233–240.
Schuler, G., Steinman, R.M., 1985. Murine epidermal Langerhans cells
mature into potent immunostimulatory dendritic cells in vitro. J. Exp.
Med. 161, 526–546.
Semnani, R.T., Law, M., Kubofcik, J., Nutman, T.B., 2004. Filaria-
induced immune evasion: suppression by the infective stage of Brugia
malayi at the earliest host-parasite interface. J. Immunol. 172, 6229–
6238.
Steinman, R.M., Swanson, J., 1995. The endocytic activity of dendritic
cells. J. Exp. Med. 182, 283–288.
Stirewalt, M.A., 1974. Schistosoma mansoni: cercaria to schistosomule.
Adv. Parasitol. 12, 115–182.
Stoitzner, P., Holzmann, S., McLellan, A.D., Ivarsson, L., Stossel, H.,
Kapp, M., Kammerer, U., Douillard, P., Kampgen, E., Koch, F.,
Saeland, S., Romani, N., 2003. Visualization and characterization of
migratory Langerhans cells in murine skin and lymph nodes by
antibodies against Langerin/CD207. J. Invest. Dermatol. 120, 266–
274.
Stoitzner, P., Tripp, C.H., Douillard, P., Saeland, S., Romani, N., 2005.
Migratory Langerhans cells in mouse lymph nodes in steady state and
inﬂammation. J. Invest. Dermatol. 125, 116–125.
220 S. Kumkate et al. / International Journal for Parasitology 37 (2007) 209–220Stoitzner, P., Tripp, C.H., Eberhart, A., Price, K.M., Jung, J.Y., Bursch,
L., Ronchese, F., Romani, N., 2006. Langerhans cells cross-present
antigen derived from skin. Proc. Natl. Acad. Sci. USA 103,
7783–7788.
Sugaya, M., Nakamura, K., Asahina, A., Fujita, H., Tada, Y., Torii, H.,
Tamaki, K., 2005. Signaling through CD40 ligand decreases CD80
expression on murine Langerhans cells and enhances IL-12 p40
production. Biochem. Biophys. Res. Commun. 331, 1045–1052.
Takahara, K., Omatsu, Y., Yashima, Y., Maeda, Y., Tanaka, S., Iyoda,
T., Clausen, B.E., Matsubara, K., Letterio, J., Steinman, R.M.,
Matsuda, Y., Inaba, K., 2002. Identiﬁcation and expression of mouse
Langerin (CD207) in dendritic cells. Int. Immunol. 14, 433–444.
Valladeau, J., Ravel, O., Dezutter-Dambuyant, C., Moore, K., Kleijmeer,
M., Liu, Y., Duvert-Frances, V., Vincent, C., Schmitt, D., Davoust, J.,
Caux, C., Lebecque, S., Saeland, S., 2000. Langerin, a novel C-type
lectin speciﬁc to Langerhans cells, is an endocytic receptor that induces
the formation of Birbeck granules. Immunity 12, 71–81.
Valladeau, J., Clair-Moninot, V., Dezutter-Dambuyant, C., Pin, J.J.,
Kissenpfennig, A., Mattei, M.G., Ait-Yahia, S., Bates, E.E., Malissen,
B., Koch, F., Fossiez, F., Romani, N., Lebecque, S., Saeland, S., 2002.Identiﬁcation of mouse langerin/CD207 in Langerhans cells and some
dendritic cells of lymphoid tissues. J. Immunol. 168, 782–792.
Villadangos, J.A., Heath, W.R., 2005. Life cycle, migration and antigen
presenting functionsof spleenand lymphnodedendritic cells: limitations
of the Langerhans cells paradigm. Semin. Immunol. 17, 262–272.
von Stebut, E., Belkaid, Y., Jakob, T., Sacks, D.L., Udey, M.C., 1998.
Uptake of Leishmania major amastigotes results in activation and
interleukin 12 release from murine skin-derived dendritic cells:
implications for the initiation of anti-Leishmania immunity. J. Exp.
Med. 188, 1547–1552.
Wang, B., Zhuang, L., Fujisawa, H., Shinder, G.A., Feliciani, C., Shivji,
G.M., Suzuki, H., Amerio, P., Toto, P., Sauder, D.N., 1999. Enhanced
epidermal Langerhans cell migration in IL-10 knockout mice. J.
Immunol. 162, 277–283.
Wheater, P.R., Wilson, R.A., 1979. Schistosoma mansoni: a histological
study of migration in the laboratory mouse. Parasitology 79, 49–62.
Zhao, X., Deak, E., Soderberg, K., Linehan, M., Spezzano, D., Zhu, J.,
Knipe, D.M., Iwasaki, A., 2003. Vaginal submucosal dendritic cells,
but not Langerhans cells, induce protective Th1 responses to herpes
simplex virus-2. J. Exp. Med. 197, 153–162.
